Pforzheim Tricuspid Valve Registry: A Real-world Observational Trial Evaluating Outcomes in Patients Treated With the Abbott TriClip™ Device in Helios Klinikum Pforzheim
Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Observational
SUMMARY
The Pforzheim Tricuspid Valve Registry study is designed to confirm the safety and performance of the TriClip™ device in a contemporary real-world setting in critically ill patients. The observational trial is a prospective, single arm, open-label, single-center, post market registry.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Subjects (\>=18 years age) have severe tricuspid regurgitation and are symptomatic despite medical therapy.
• Subjects eligible to receive the TriClip™
• Subjects must provide written informed consent prior to study procedure.
Locations
Other Locations
Germany
Helios Klinikum Pforzheim
RECRUITING
Pforzheim
Contact Information
Primary
Ilka Ott, MD, PhD
Ilka.Ott@helios-pforzheim.de
+4972319692955
Backup
Alexandru Patrascu, MD
alexbasket23@yahoo.com
+491736964480
Time Frame
Start Date: 2020-11-30
Estimated Completion Date: 2026-11-30
Participants
Target number of participants: 200
Treatments
Heart Failure Patients
Patients suffering from symptoms of right heart failure due to high-grade tricuspid regurgitation
Related Therapeutic Areas
Sponsors
Leads: Helios Klinikum Pforzheim